
PhD candidate in molecular fortune telling @TUeindhoven 🇳🇱 - @molecularML. Follow me on BlueSky: https://xitter.gq/t.co/BPTUmQWs31
The Netherlands
Joined September 2018
- Tweets98
- Following485
- Followers662
- Likes849
Pinned Tweet
Happy to finally share our latest paper on active deep learning in low-data drug discovery in @NatComputSci!
We tried to answer some open questions to get ready for prospective application 🧵👇
#AI #chemistry #drugdiscovery
@fra_grisoni @molecularML
rdcu.be/dViua
We just preprinted a fresh study on molecular machine learning on OOD molecules 🧠
Using joint modeling, we could detect distribution shifts, estimate prediction reliability, and capture meaningful molecular patterns!
doi.org/10.26434/chemrxiv-20…
#AI #chemistry @molecularML
I have moved to bluer pastures.
Follow me at BlueSky at derekvtilborg.bsky.social
99
I want to delete my twitter account because of the Muskonian nature of this platform. What is the best alternative medium to stay in touch with the scientific community?
1
303
Derek van Tilborg retweeted
🚨Excited to share our new preprint:
"Automated navigation of condensate phase behavior with active machine learning"
doi.org/10.26434/chemrxiv-20…
@fra_grisoni @molecularML
In collaboration with:
Luc Brunsveld & Jan van Hest groups!
#MachineLearning #PhaseSeparation #automation
👇
A must read if you're doing molecular machine learning chemrxiv.org/engage/chemrxiv…
A good read on the perceived success of molecular machine learning. Don't forget your statistical tests guys!
nature.com/articles/s42256-0…
Derek van Tilborg retweeted
📢 JOB ALERT 📢
My team @molecularML is searching for a #postdoc with a background in medicinal chemistry! 👩🔬👨🔬🧪
Do you have the experience?
Are you eager to contribute to #AI for discovering new drugs?
👉Then DM me!
Funded by @ERC_Research and located at @TUeindhoven 🚀
We also played with the molecular diversity of the start data. We found that it doesn't really matter!
Even if you start out with very low molecular diversity, you will quickly get rid of it with active learning (a) compared to a control method (b).
De novo drug design was getting stale until @Rza_ozcelik came along with state space models to spice it up. Even though I'm totally biased, I think its really well done work :)
🥳🥳I'm thrilled that our work that introduces the state space models (SSMs) into de novo design is now published at @NatureComms 🎉 🎉 nature.com/articles/s41467-0…
w/ Sarah de Ruiter, Emanuele Criscuolo, and @fra_grisoni @molecularML
3
361
Playing with #AI is nice, but applying it is the real deal!
Within 3 cycles, we optimized nanoparticle uptake in cancer cells by almost 15 fold. Cool for drug delivery, but mostly a lot of fun🧪
@AnaOrPe_ @rvdmnanomeds @fra_grisoni @Fluo_renzo
paper: doi.org/10.1039/D4DD00104D
Thrilled of our collaboration with the team of @Fluo_renzo, spearheaded by a great duo @AnaOrPe_ & @DerekvTilborg. 🚀
We show the integration of active #machinelearning, microfluidics, and imaging for nanoparticle design.
Just out on @digital_rsc 💪🏻
pubs.rsc.org/en/content/arti…
Our (mini) review on deep learning for low-data drug discovery is now out!
doi.org/10.1016/j.sbi.2024.1…
There are honestly few things I enjoy as much as writing a review. It's so satisfying
Especially together with @hlnbrnkmnn @emanuelecriscu9 Luke Rossen @Rza_ozcelik @fra_grisoni
Check out our new review on "Deep learning for low-data #drugdiscovery"!
We discuss ML strategies to deal with our most pressing problem; ✨ low-data ✨
doi.org/10.26434/chemrxiv-20…
@hlnbrnkmnn @emanuelecriscu9 Luke Rossen @Rza_ozcelik @fra_grisoni @molecularML
#AI #chemistry
2. Multi-staged training, where we discuss transfer learning, reinforcement learning, and active learning.
1
1
458
And 3. Context-enriched training, where we talk about the applications of multimodal training and multi-task learning.
Besides these three main avenues of dealing with low-data problems, we end the review by highlighting challenges and future opportunities. 🧠✨🧪
1
362
@fra_grisoni had the idea of writing this review in 1 day with the group. We all came prepared and crunched out a messy draft in one work day. The rest definitely took more than a day (a lot longer), but it was a nice kickstart and teambuilding event :)
2
319
We cover three main topics:
1. Data augmentation, where we talk about how to augment molecular data.
1
1
537
Check out our new review on "Deep learning for low-data #drugdiscovery"!
We discuss ML strategies to deal with our most pressing problem; ✨ low-data ✨
doi.org/10.26434/chemrxiv-20…
@hlnbrnkmnn @emanuelecriscu9 Luke Rossen @Rza_ozcelik @fra_grisoni @molecularML
#AI #chemistry













